Status:

COMPLETED

The "START" (a Streamlined ART Initiation Strategy) Study

Lead Sponsor:

University of California, San Francisco

Conditions:

HIV

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

START is clinic-level (not individual-patient) intervention to catalyze the process of ART initiation among HIV-infected adults who meet CD4-based criteria for combination ART (e.g., adults with a CD4...

Detailed Description

RATIONALE: In Africa, up to a 50-75% of HIV-infected, adults fail to initiate (FTI) ART or encounter delays of months even after eligibility through CD4+ T-cell testing or clinical criteria are establ...

Eligibility Criteria

Inclusion

  • All MJAP-supported clinics in Kampala and Mbarara Districts

Exclusion

  • None.

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2016

Estimated Enrollment :

12024 Patients enrolled

Trial Details

Trial ID

NCT01810289

Start Date

April 1 2013

End Date

August 1 2016

Last Update

November 7 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The "START" (a Streamlined ART Initiation Strategy) Study | DecenTrialz